HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

Tirzepatide cut 3-year diabetes incidence to 1.3% vs 13.3% in SURMOUNT-1

Louis Nervegna · Mar 06, 2025 · ♥ 12 reactions · 5 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)Weight, visceral & liver fatInsulin resistance & diabetes
AI summary & key facts

Louis shares Luigi Fontana's post on the 3-year SURMOUNT-1 results and adds that weight loss clears fat from liver and pancreas, the main cause of insulin resistance and beta-cell dysfunction, so any diet producing major weight loss can do the same. The shared post also warns about muscle/bone loss and nutrient deficiencies without exercise and good nutrition.

More evidence that GLP-1 agonists stop the progression of diabetes, and lead to reversal in many cases.

The mechanism is very simple: Significant weight loss clears the liver and pancreas of fat, which is the principle cause of both insulin resistance and beta cell disfunction.

You don’t need a drug to do this. Any diet that results in significant weight loss will do it.

#glp1HD #liverfatHD #pancreasfatHD #visceralfatHD #weightlossHD #reversediabetesHD #betacellsHD

Research cited

Tirzepatide Shows Promise, but Is It the Full Solution for Long-Term Health?

The latest 3-year results from the SURMOUNT-1 trial confirm what we already know: obesity is a chronic disease, and effectively treating it can significantly reduce the risk of type 2 diabetes.

Paper · N Engl J Med · 2025Tirzepatide for Obesity Treatment and Diabetes Preventionnejm.org

In this study, tirzepatide led to substantial and sustained weight loss while dramatically lowering diabetes progression in individuals with obesity and prediabetes.

📉 Weight Reduction at 176 Weeks
▪️ -12.3% (5 mg)
▪️ -18.7% (10 mg)
▪️ -19.7% (15 mg)
▪️ -1.3% (placebo)

⚡ Diabetes Risk Reduction
▪️ 1.3% of tirzepatide users vs. 13.3% of placebo users developed type 2 diabetes during treatment

While these results are impressive, weight loss alone is not the key to healthy longevity. There are critical concerns:
✅ Muscle & Bone Loss – Losing weight without preserving lean mass with a well designed exercise program leads to sarcopenia, lower bone mass, and potentially frailty, especially as we age.
✅ Nutrient Deficiencies – Simply eating less, particularly in the context of an ultra-processed high-animal products Western diet, can lead to malnutrition, low fiber intake, and gut microbiome disruptions due to reduced phytochemicals and essential nutrients, impacting metabolism and immune function.

The real challenge? Weight management strategies must go beyond just reducing calories. Sustainable health requires:
🥦 Whole, nutrient-dense primeraly plant foods that nourish the microbiome and activates anti-aging pathways
🏋️ Resistance training coupled with endurance exerciseto maintain muscle and bone health
🔬 Personalized approaches to ensure metabolic flexibility

Tirzepatide is a powerful tool, but it’s not the full answer to long-term health and longevity. The future lies in prevention with healthy lifestyle and when necessary integrating pharmacologic interventions with nutritional and lifestyle strategies that support metabolic health, muscle integrity, and microbiome diversity.

No photo description available.
← newer: Replacing butter with plant oils linked to 17% lower mortaliolder: SGLT2 inhibitors may offer benefits beyond diabetes, argues →